APA (7th ed.) Citation

Ullah, W., Uddin, G., Rauf, A., Khan, M. U., Akram, Z., Shabbir, C. A., . . . Iriti, M. (2025). Dual Therapeutic Potential of Novel Cornallegic Acid: In Vitro Anti-inflammatory and ROS Suppression with Computational Insights from Docking, ADMET and DFT Studies. Journal of Computational Biophysics & Chemistry, 24(10), 1385. https://doi.org/10.1142/S2737416525500279

Chicago Style (17th ed.) Citation

Ullah, Wali, Ghias Uddin, Abdur Rauf, Muhammad Umer Khan, Zuneera Akram, Chaudhry Ahmed Shabbir, Walaa F. Alsanie, Abdulhakeem S. Alamri, and Marcello Iriti. "Dual Therapeutic Potential of Novel Cornallegic Acid: In Vitro Anti-inflammatory and ROS Suppression with Computational Insights from Docking, ADMET and DFT Studies." Journal of Computational Biophysics & Chemistry 24, no. 10 (2025): 1385. https://doi.org/10.1142/S2737416525500279.

MLA (9th ed.) Citation

Ullah, Wali, et al. "Dual Therapeutic Potential of Novel Cornallegic Acid: In Vitro Anti-inflammatory and ROS Suppression with Computational Insights from Docking, ADMET and DFT Studies." Journal of Computational Biophysics & Chemistry, vol. 24, no. 10, 2025, p. 1385, https://doi.org/10.1142/S2737416525500279.